If any of these mechanisms, including complement or antibody deficiency, problems in the TLR signaling cascade (such as MYD88 or IRAK4 mutations), or congenital asplenia, are lacking in children, they are at a higher risk of recurrent or severe IPD [11,12]. This evidence concerns the gene MYD88 and agammaglobulinemia.